MOMartins Obinna Ogugofor

Martins Obinna Ogugofor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martins Obinna Ogugofor has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deciphering the therapeutic actions of Brenania brieyi (Rubiaceae) fractions on oxidoinflammatory anomalies

    by Ifeoma Felicia Chukwuma, Victor Onukwube Apeh, Florence Nkechi Nworah, Lawrence U S Ezeanyika, Victor Nwadiogo Ogugua, Abayomi Emmanuel Adegboyega, Martins Obinna Ogugofor

    A decline in the antioxidant network during the inflammatory response plays a critical role in the pathogenesis of numerous diseases. We designed this study to decipher the therapeutic efficacy of Brenania brieyi in reducing oxidative stress caused by the inflammatory response to cotton pellets. Graded doses of methanol and chloroform fractions of B. brieyi (MFBB and CFBB) and indomethacin were administered to Wistar rats for seven days after implanting sterilised cotton pellets (20 mg). Thereafter, biochemical indices of oxidative stress were determined using blood samples taken through cardiac puncture. Furthermore, molecular interactions, drug-likeness, and toxicity features of B. brieyi phytochemicals were also assessed. Compared with the untreated group, the groups treated with MFBB and CFBB had a significant (p < 0.05) decrease in granuloma tissue weight and MDA levels while increasing glutathione levels, SOD, and CAT activities. In addition, a substantial increase in inflammatory-induced changes in antioxidant nutrients, together with a decline in liver enzymes, was obtained in the treated groups. The docking tests revealed that the top-scoring phytoconstituents of B. brieyi, n-hexadecanoic acid, and 9-octadecanoic acid interacted well with catalase, having docking scores of -6.19 and -7.58 kcal/mol, respectively. Moreover, the hits had good oral drug-likeness features and a safe toxicity profile. The findings of the study provide evidence that B. brieyi has antioxidant and anti-inflammatory properties, suggesting that it could be used as an alternative therapy to regulate oxidative stress-related diseases.


  • Open Access

    An investigation of the phytochemical richness of fresh Musa paradisiaca L. (plantain) stem juice and its anticonvulsant potential on pentylenetetrazole (PTZ)-challenged rats

    by Sabastine Chinweike Ugwuoke, Valentine Odirachukwumma Nwanelo, Yusufu Dawoye, Obiora Celestine Ugwu, Dionysius Obinna Osuji, Martins Obinna Ogugofor, Ikechukwu Jacob Okoro, Chigozie Paul Odo, Treasure Nneka Nelson, Chioma Assumpta Anosike

    This study was aimed at determining the therapeutic value of fresh Musa paradisiaca L. (MP) stem juice as a potential treatment for epileptic convulsions using a pentylenetetrazole (PTZ)-induced seizure model in rats. Six groups of albino rats (n = 4) were involved in the study. Group I was treated with normal saline (p.o), while group II was untreated and group III received diazepam (4 mg/kg, p.o). Group IV, V and VI received 50, 75 and 100% v/v oral dose of MP stem juice, respectively). The treatment lasted for 10 days, followed by PTZ (85 mg/kg b.w, i.p) administration 60 min later. Lethality test and phytochemical screening were conducted. The rats were closely watched and meticulously monitored for seizure manifestations/episodes with the aid of a stop watch. From the results, the MP stem juice up to 100% (v/v) was safe in mice and numerous bioactive compounds were found with phenols being the most abundant (9.46 ± 0.03 mg/g), followed by alkaloids (5.54 ± 0.98 mg/g) and flavonoids (4.27 ± 1.23 mg/g). For the seizure manifestation, three intermittent seizures (episodes 1, 2 and 3) were observed and the stem juice (75 and 100% v/v) significantly (p < 0.05) increased the latency periods of episode 1 tonic and clonic seizures. The stem juice at 50% (v/v) delayed the onset of episode 2 seizures for over 10 minutes more than the untreated group. The groups that received 75 and 100% (v/v) of the stem juice did not experience seizures during the episode 2 as seen in episode 1. The standard and the test groups did not experience seizure during the episode 3. The findings of this study have demonstrated that the fresh MP stem juice could prevent convulsions by increasing the latencies and decreasing relatively the durations of seizures in PTZ-challenged rats. This study, however, provides the pharmacological evidence for the folk claim behind the use of Musa paradisiaca stem juice to manage epileptic convulsions or seizure disorders.

  • Glyphaea brevis (Spreng) Monachino (Tiliaceae) leaf fractions protect against pentylenetetrazole (PTZ)-induced convulsion in mice

    by Ugochi O. Njoku, Martins O. Ogugofor

    Purpose: To investigate the anticonvulsant effect of Glyphaea brevis leaf fractions using a pentylenetetrazole (PTZ)-induced seizure model in mice. Methods: Glyphaea brevis leaf methanol extract was partitioned using n-hexane and hydro-methanol (8:2). Seizure was assessed in terms of onset of myoclonic and tonic-clonic seizure, duration of seizure and frequency of seizure. The concentrations of glutathione of catalase, glutathione peroxidase, superoxide dismutase and malondialdehyde in the brain of the mice were also determined. Results: The administration of the different fractions of Glyphaea brevis leaf prior to induction of seizure with PTZ prolonged the latency of convulsion in mice as well as a significant (p < 0.05) decline in the intensity of convulsion was observed. In relation to the untreated mice, there was a rise in the levels of glutathione peroxidase, superoxide dismutase, and catalase in the brain, but a decrease in malondialdehyde levels. Conclusion: The study results show that the fractions of Glyphaea brevis leaf have anticonvulsive properties, proving that the plant’s use in folklore medicine for treating convulsion.


  • Open Access

    Phytochemical analysis and thrombolytic profiling of Costus afer stem fractions

    by Martins Obinna Ogugofor, Ugochi Olivia Njoku, Obioma Uzoma Njoku, Gaber El-Saber Batiha

    Background: The most commonly occurring mechanism driving ischemic heart disease, ischemic stroke, and myocardial infarction is thrombosis. It is normally characterized by platelet activation and aggregation. Thrombolytics have been used in the treatment of several forms of thrombosis, but their adverse effects have limited their usefulness. Thus, there is a need to develop alternatives from medicinal plants known to possess antithrombotic activity such asCostus afer.Results: The phytochemical evaluations indicated the presence of flavonoids, alkaloids, cardiac glycosides, tannins, terpenoids, and saponins. The antithrombotic profiling showed that streptokinase had the highest percentage clot lysis, followed by ethylacetate fraction of the extract, which was higher than aspirin and other fractions of the extract.Conclusion: The present findings show thatC. aferstem extract and various fractions possess antithrombotic activities. However, further studies are needed to characterize the antithrombotic bioactive compounds present in the different fractions that are responsible for the activities.


  • Open Access

    Identification and Characterization of Phytochemicals and Constituents in Desmodium Velutinum Stem Using High Performance Liquid Chromatography (Hplc)

    by Chinelo Nkwocha, Martins Ogugofor, Ifeoma Chukwuma

    The aim of this study was to analyse and identify phytochemicals and bioactive constituents present in Desmodium velutinum stem. Fresh stems of Desmodium velutinum were air dried at room temperature for 3 days. The stems were pulverized into fine powder which was extracted with methanol (80% v/v). The concentrated extract was fractionated using n hexane, ethylacetate and aqueous methanol. Phytochemical analyses and bioactive composition were done using standard methods and HPLC. The fractionation of 40 g Desmodium velutinum stem methanol extract using aqueous methanol gave a 16% percentage yield. The phytochemical analyses showed the presence of tannins, flavonoids, phenolics and alkaloids with concentrations 5.02±1.22 mg/g, 2.64±0.01 mg/g, 7.02±1.18 mg/g and 3.61±0.04 mg/g respectively. The high-performance liquid chromatography (HPLC) analysis of the aqueous fraction of Desmodium velutinum stem showed the presence of different constituents of flavonoids, phenols, and tannins in varying concentrations. The flavonoids include rutin hydrate and apigenin. The phenols identified were p-coumaric acid, rutin, ferrulic acid, and apigenin while the tannins identified were tannic acid. These phytochemicals identified in Desmodium velutinum stem have been reported to possess antioxidant properties which may be used in preventing and alleviating diseases. Desmodium velutinum may therefore be a potential source of new drugs in orthordox medicine.

  • Open Access

    Potential Enhancement of Metformin Hydrochloride in Lipid Vesicles Targeting Therapeutic Efficacy in Diabetic Treatment

    by Emmanuel Chekwube Ossai, Augustine Chidi Madueke, Benjamin Emenike Amadi, Martins Obinna Ogugofor, Audu Mumuni Momoh, Charles Odilichukwu R. Okpala, Chioma Assumpta Anosike, Obioma Uzoma Njoku

    The potential enhancement of metformin hydrochloride (MH) loaded in lipid vesicles targeting therapeutic efficacy on alloxan-induced diabetic rats was investigated. This involved lipid vesicles formulated with homogenously distributed nano-sized particles by a novel integrated process of multiple emulsification by membrane and solvent evaporation. The average diameter of the water-in-oil (W1/O), W1/O/W2 emulsion droplets, and lipid vesicles was 192 nm, 52 µm, and 173 nm, respectively. The entrapment yield of metformin hydrochloride (MH) in the prepared lipid vesicles was 40.12%. The metformin hydrochloride-loaded lipid vesicles (MH-LLVs) sustained the release of the entrapped drug over a 12-h period and reduced the plasma glucose level of diabetic rats by 77.4% compared with free MH solution (2-h period and 58.2%, respectively) after one week post-diabetic treatment through oral administration of MH-LLV and the free drug. The remarkable improvement in the biochemical parameters recorded in the MH-LLV-treated animals compared with those that received free MH solutions depicted an enhanced kidney function, liver function, as well as oxidative stress status. Pancreatic histology depicted a pancreas with intralobular ducts (ID) and exocrine secretory acini that characterize an intact pancreas, which suggests the ability of the MH-LLVs to restore pancreatic cells to normal, on a continued treatment. Overall, MH-LLV appears an encouraging extended-release formulation with enhanced bioavailability, sustained release, and improved antihyperglycemic potentials.


  • Open Access

    Ethyl acetate fraction of Cola hispida leaf protects against doxorubicin-induced myocardial injury in male albino rats

    by Chiemeka Lynda Umenwanne, Martins Obinna Ogugofor, Obioma U. Njoku

    Background: Cardiovascular diseases have continued to be the leading cause of death globally. In addition, some of the drugs used in the treatment of the diseases present some adverse effects which limit the usefulness of such drugs. Thus, there is a need for novel drugs whose side effect is either minimal or non-existent. The presence of bioactive compounds in Cola hispida leaf is of great significance in the treatment and management of cardiovascular conditions. This study investigated the cardio-protective potential against doxorubicin (Dox)-induced cardiac infarction in rats. Results: Dox induction resulted to muscle fiber degeneration in Dox-treated rats hence revealed significant (p < 0.05) elevation in the serum level of cardio biomarker enzymes and lipid peroxidation profile while significant (p < 0.05) fall in cardiac enzymatic antioxidant levels were observed relative to the normal control. Pre-treatment with ethyl acetate fraction of Cola hispida leaf expressed cardio-protective potentials against Dox-induced cardiotoxicity by significantly (p < 0.05) lowering the levels of cardiac biomarker enzymes towards normal, building up the activities of subdued antioxidant enzymes and depleting its malondialdehyde level. Histopathology photomicrograph of the heart tissues expressed myxomatous degeneration but was ameliorated through the administration of the fraction. Conclusion: In accordance with the findings from this study, the administration of ethyl acetate fraction of Cola hispida leaf is effective against Dox-induced redox imbalance due to its enriched antioxidant phytoconstituents.


  • Open Access

    Gastro-protective Properties of Acalypha torta Leaf against HCl/Ethanol-Induced Ulceration

    by Ugochi Njoku, Bonaventure Uzowuru, Martins Ogugofor

    A peer-reviewed, open access online international journal which publishes original research papers. The journal welcomes submission from scholars and experts for possible publication from all over the world. The scope of the journal includes: Pharmaceutical research, chemistry and biochemistry of naturally occurring compounds, biological evaluation of crude extracts, ethnomedicine, traditional and complementary medicine, ethnopharmacology, biomedical research, Biotechnology, Evaluation of natural substances of land and sea and of plants, microbes and animals, pharmacognosy, bioavailability, clinical, pharmacological, toxicological studies and pharmacokinetics of phytochemicals, Isolation and characterization of compounds, structure elucidation, synthesis and experimental biosynthesis of natural Product as well as developments of methods in these areas are welcomed in the journal.